The lawsuit alleged a years-long insulin pricing scheme that artificially inflated the price of lifesaving diabetes medications and deceived consumers about those inflated prices.
David Joyner, the chief executive officer of CVS Health, predicted at a U.S. House committee hearing in 2024 that patients, insurers, employers and other U.S. payers could soon be spending $1 trillion ...
In fact, 82% of hourly workers with access to a plan are saving, while 75% of those without access aren’t saving at all.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback